Resveratrol and Its Derivatives Diminish Lipid Accumulation in Adipocytes In Vitro—Mechanism of Action and Structure–Activity Relationship
Resveratrol and its analogues can mimic caloric restriction with complex mechanisms, including activation of SIRT1, PGC-1α, and JNK, making them possible drug candidates to treat obesity-related diseases.
Authors
- Éva Szökő (ORCID: https://orcid.org/0000-0003-1464-6403)
- Kamilla Varga (ORCID: https://orcid.org/0000-0002-4533-0404)
- Tamás Tábi (ORCID: https://orcid.org/0000-0001-5343-0205)
- Csenge Böröczky
- Alexandra Paszternák
- Noémi Sikur
- Ramá Gyöngyössy
Institutions
- Semmelweis University (HU)
Publication Details
- Journal
- Nutrients
- Published
- 2024-11-13
- DOI
- https://doi.org/10.3390/nu16223869
- Citations
- 3
- Primary Topic
- Sirtuins and Resveratrol in Medicine
- Type
- article
- Field-Weighted Citation Impact
- 1.03
Funders
- Semmelweis Egyetem